1-6 of 6
Jamshid Khorashad, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Partially or Fully BCR-ABL Independent Mechanisms of in Vitro Resistance to Ponatinib

Qian Yu, BS, Anna M Eiring, PhD, Matthew S. Zabriskie, Jamshid Khorashad, MD, PhD, David J Anderson, BS, Jade A Bryant, BS, Marc M Loriaux, MD, PhD, Jeffrey W Tyner, PhD, Thomas O'Hare, Michael W. Deininger
Journal: Blood
Blood (2011) 118 (21): 2481.
https://doi.org/10.1182/blood.V118.21.2481.2481
Published: 2011
Journal Articles

Intrinsic and Extrinsic Survival Signals Converge on STAT3 As a Critical Mediator of BCR-ABL-Independent Tyrosine Kinase Inhibitor Resistance,

Anna M Eiring, PhD, Ira L Kraft, BS, David J Anderson, BS, Elie Traer, MD, PhD, Qian Yu, BS, Jamshid Khorashad, MD, PhD, Thomas O'Hare, Michael W. Deininger
Journal: Blood
Blood (2011) 118 (21): 3742.
https://doi.org/10.1182/blood.V118.21.3742.3742
Published: 2011
Journal Articles

Frequency and Clonality of BCR-ABL Compound Mutations in Chronic Myeloid Leukemia,

Jamshid Khorashad, MD, PhD, Todd W. Kelley, MD, Philippe Szankasi, PhD, Lauren T. Adrian, Christopher A. Eide, Matthew S. Zabriskie, Thoralf Lange, MD, Ira L Kraft, BS, Anna M Eiring, PhD, Thomas O'Hare, Michael W. Deininger
Journal: Blood
Blood (2011) 118 (21): 3744.
https://doi.org/10.1182/blood.V118.21.3744.3744
Published: 2011
Journal Articles

Chronic Myeloid Leukemia Patients on Tyrosine Kinase Inhibitor Have Normal T Cell Responses to Vaccination but An Impaired IgM Humoral Response Associated with Loss of Discrete Memory B Cell Subsets,

Hugues de Lavallade, MD, David Marin, Melanie Hart, Takuya Sekine, Ian Gabriel, MD, Abdullah Alsuliman, Alexandra Bazeos, Ahmad Khoder, Dr, Kate Stringaris, MD, MRCP, FRCPath, Jamshid Khorashad, MD, PhD, Nichola Cooper, MD, Dragana Milojkovic, MD, Letizia Foroni, MD PhD, Richard M Szydlo, Aristeidis Chaidos, Amr R Ibrahim, Marco Bua, MD, John M Goldman, Jane F Apperley, MBChB, MD, FRCP, FRCPath, William P Kelleher, MD, PhD, Katayoun Rezvani
Journal: Blood
Blood (2011) 118 (21): 3753.
https://doi.org/10.1182/blood.V118.21.3753.3753
Published: 2011
Journal Articles

The Natural History of RTQ-PCR Levels After the Achievement of Complete Molecular Remission (CMR): Implications for ‘Stopping' Studies

Dragana Milojkovic, MD, Gareth Gerrard, PhD, Christos Paliompeis, Marco Bua, MD, Alistair Reid, PhD, Mary Alikian, Jamshid Khorashad, MD, PhD, John M Goldman, David Marin, Letizia Foroni, MD PhD, Jane F Apperley, MBChB, MD, FRCP, FRCPath
Journal: Blood
Blood (2011) 118 (21): 605.
https://doi.org/10.1182/blood.V118.21.605.605
Published: 2011
Journal Articles

Response to Tyrosine Kinase Inhibitor Therapy In Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Phase Chronic Myeloid Leukemia

Ailsa Holroyd, MD, Elizabeth Phillips, MD, Richard Szydlo, PhD, David Marin, MD, PhD, Letizia Foroni, MD, PhD, Jamshid Khorashad, MD, PhD, Dragana Milojkovic, MD, PhD, Edward J. Kanfer, MD, Francesco Dazzi, Donald H. MacDonald, MD, PhD, Amin Rahemtulla, MBBS, PhD, FRCP, Donal McLornan, MD, PhD, Ian H Gabriel, MD, Jiri Pavlu, MD, Jeremy Sargent, MD, John M. Goldman, MD, PhD, Jane F. Apperley, MD, Katayoun Rezvani, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3515.
https://doi.org/10.1182/blood.V116.21.3515.3515
Published: 2010